Anzeige
Mehr »
Dienstag, 21.04.2026 - Börsentäglich über 12.000 News
BREAKING: Pacifica liefert hochgradige Treffer - Phase II trifft genau ins Ziel
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
17:54Arcus Biosciences stock rating held at Neutral by BofA on rival trial data
17:54Jefferies reiterates Churchill Downs stock rating on Preakness deal
17:42Revolution Medicines to present phase 3 pancreatic cancer data at ASCO
17:42Galliford Try wins £750m affordable homes framework contract
17:42Raymond James raises Altius Minerals stock price target on revenue growth
17:42William Blair reiterates Eupraxia stock rating on trial data
17:42BofA raises PG&E stock price target to $23 on capital investment
17:42Blue Bird stock rating reiterated at Buy by Craig-Hallum on strong positioning
17:42Magnite stock rating maintained at Buy by Craig-Hallum amid exits
17:42BofA raises Synchrony Financial price target on volume trends
17:18Kemper completes sale of captive agent business to Confie
17:18Klarna resell feature sees 75% growth in listings over 13 months
17:18Prosus non-executive director Steve Pacak passes away
17:18Macquarie raises Rio Tinto stock price target on aluminum strength
17:18Telsey reiterates Tractor Supply stock rating after soft quarter
16:54Black Diamond to present silevertinib data at ASCO meeting
16:54Karyopharm's myelofibrosis trial selected for ASCO presentation
16:54Regeneron submits U.S. application for gMG treatment cemdisiran
16:54Immunome's desmoid tumor trial data selected for ASCO presentation
16:54RBC Capital reiterates Westlake Chemical stock rating on new CFO
16:54RBC Capital maintains Shopify stock rating on strong e-commerce data
16:54Mizuho raises GE Vernova stock price target on data center demand
16:54Jefferies raises FirstEnergy stock price target on regulatory outlook
16:54UBS reiterates Buy on Block stock, $90 target on design focus
16:54RBC Capital reiterates Exelixis stock rating on competitive position